<DOC>
	<DOC>NCT02593396</DOC>
	<brief_summary>The purpose of this study is to assess the tolerability, safety, and efficacy of bupropion hydrochloride sustained-release in the treatment of sexual dysfunction in men on methadone maintenance therapy.</brief_summary>
	<brief_title>Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men</brief_title>
	<detailed_description>This is a single-center (University Malaya Medical Centre), randomized, double-Blind, placebo-controlled versus bupropion hydrochloride sustained-releases study trial on 70 men who have methadone emergent sexual dysfunction. Bupropion hydrochloride sustained-release (Wellbutrin SR) 150mg once a day for 7 days then 150mg twice a day for 42 days. Taken orally by the subjects.The total duration of the study is expected to be 24 months. 20months for subject recruitment and 4 months for final subject follow-up. The primary endpoint is Mean improvement in scores on the Clinical Global Impression Scale adapted for sexual Function (CGI-SF). Secondary endpoints are Change from baseline International Index of Erectile Function (IIEF-15) score. Mean improvement in scores on the sexual desire inventory 2 (SDI2). Other evaluation included: Montgomery-Åsberg Depression Rating Scale (MADRS- Malay version ), Mini International Neuropsychiatric Interview (M.I.N.I), Opiate Treatment Index (OTI), World health organization Quality of Life-Brief Scale (WHOQoL-Brief, Malay version), Malay Version of the Golombok-Rust Inventory of Marital State (Mal-GRIMS) and Rapid urine drug test. Safety evaluation included: Incidence of adverse events. Data will be analyzed using linear mixed-effects model.</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Had a diagnosis of opioid dependence base on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) criteria While taking a stable dose of methadone In UMMC (University Malaya Medica Centre) and University Malaya centre of Addiction Science (UMCAS) outpatient clinic for ≥ 6 months Were experiencing constant sexual dysfunction for ≥ 4 weeks Were in a stable sexual relationship with a female partner for ≥ 6 months Severe behavior disturbances or psychotic symptoms Obvious organic illnesses caused the sexual dysfunction (such as diabetics or patients with heart and vascular disease) Those with history of sexual dysfunction before methadone therapy Receiving antiviral treatment for viral hepatitis or HIV, or androgen replacement treatment. History of an eating disorder (eg, anorexia, bulimia) or seizures (eg, epilepsy) Using other psychotropic medications other than methadone Clinical significant abnormal laboratory values. Clinically significant abnormal ECG. Documented history of other psychiatric diagnosis (schizophrenia, bipolar disorder, major depressive disorder, organic brain disorder, dementia etc.) Refused to give participate.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>sexual dysfunctions</keyword>
	<keyword>erectile dysfunctions</keyword>
	<keyword>hypoactive sexual desire dysfunctions</keyword>
</DOC>